000 04296nam a22004575i 4500
999 _c128007
_d128007
_x1
001 128007
003 ES-MaUEC
005 20230102114329.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 200828s2020 gw | s |||| 0|eng d
020 _a9783030517366
024 7 _a10.1007/978-3-030-51736-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC776.P85
_b2020 EB
245 0 0 _aPulmonary Embolism :
_bFrom Acute PE to Chronic Complications
_cedited by Belinda Rivera-Lebron, Gustavo A. Heresi
250 _aFirst edition
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2020
300 _a1 recurso en línea (VIII, 218 páginas)
_b40 ilustraciones, 32 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aarchivo de texto
_bPDF
490 1 _aRespiratory Medicine
_x2197-7372
490 0 _aMedicine (SpringerNature-11650)
490 0 _aMedicine (R0) (SpringerNature-43714)
505 0 _aEpidemiology of Pulmonary Embolism -- PE Diagnosis -- Risk Stratification of Acute PE -- Bleeding Risk Considerations Prior to Initiation and Duration of Anticoagulation Therapy for the Treatment of Venous Thromboembolism -- Treatment for Pulmonary Embolism: Anticoagulation Selection and Duration -- Indications for systemic thrombolysis over anticoagulation -- Endovascular techniques in the treatment of acute PE -- Role of surgical embolectomy and ECMO in PE -- Inferior Vena Cava filters in Venous Thromboembolism - Multidisciplinary PE response team (PERT) development and implementation -- Post-PE Management -- Epidemiology and Diagnosis of Chronic Thromboembolic Pulmonary Hypertension -- Medical, Endovascular and Surgical Treatment of CTEPH.
520 3 _aThis book is a comprehensive guide to the diagnosis and management of all stages of pulmonary embolism, starting with acute and ending with chronic thromboembolic pulmonary hypertension. Acute pulmonary embolism (PE) is responsible for 150-250,000 hospitalizations and 60-100,000 deaths each year in the United States, making it the third most common cause of cardiovascular death. Acute PE spans a wide spectrum of clinical outcomes mainly based on the right ventricle's (RV) capacity to tolerate strain. There have been many recent advances in the field of PE, including guidelines on classification and risk stratification, anticoagulation, as well as evolving areas in treatment options and follow up. The text begins with a review of the epidemiology and risk factors for PE. Chapters then delve into reviewing the decision pathways based on PE severity and treatment options, including the use of oral anticoagulation, systemic and catheter-directed thrombolysis, mechanical and surgical thrombectomy, and hemodynamic support with extracorporeal membrane oxygenation. The text then focuses on post-PE complications such as post-PE syndrome, chronic thromboembolic disease, and chronic thromboembolic pulmonary hypertension (CTEPH). This is an ideal guide for providers of lung health, including pulmonary and critical care physicians, cardiologists, thoracic and cardiovascular surgeons. Physician-trainees, physician assistants, nurses and respiratory therapists with interest in pulmonary disorders, cardiovascular disease, pulmonary embolism, critical care or pulmonary hypertension will also find great value in this comprehensive guide.
988 _aSpringer_Medicine_2020
650 7 _aEmbolia pulmonar
_2embne
_9147482
650 7 _aAparato respiratorio
_xEnfermedades
_2embne
_9405936
650 7 _aCuidados intensivos
_2embne
_9141442
700 1 _aRivera-Lebron, Belinda
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aHeresi, Gustavo A.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030517359
776 0 8 _iPrinted edition:
_z9783030517373
776 0 8 _iPrinted edition:
_z9783030517380
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-51736-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _dz
_b01/2021
_eo
_zSI